LD-2 disclosure · 4th Quarter - Report
ALLERGAN INC (FORMERLY ACTAVIS INC )
Client
- Name
- ALLERGAN INC (FORMERLY ACTAVIS INC )
- Description
- Pharmaceutical manufacturer specializing in generic, brand and biosimilar products.
- Location
- District of Columbia · United States of America
Registrant
- Description
- Government affairs consulting
- Location
- Washington, DC, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Issues related to FDA draft guidance and scientific data review, including HR 2029, the Consolidated Appropriations Act of 2016.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Analyst for the Senate Republican Policy Committee
Covered position (BRENDA REESE): Conference Coordinator for the House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES
Copyright/Patent/Trademark
Issues concerning patent reform, including H.R. 9 The Innovation Act, and S. 1137, the Protecting American Talent and Entrepreneurship Act.
LobbyistsDIANE MAJOR · BRENDA REESE
Covered position (DIANE MAJOR): Health Policy Analyst for Senate Republican Policy Committee
Covered position (BRENDA REESE): Conference Coordinator for House Republican Conference
TargetedSENATE · HOUSE OF REPRESENTATIVES
